# Abercrombie & Fitch Co: overview

ANF · NYSE · CIK 1018840 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/anf.md) · [Financials](/companies/anf/financials.md) · [Filings](/companies/anf/filings.md) · [Insiders](/companies/anf/insiders.md)

Latest reported revenue: [$1.27bn](/filings/0001018840-26-000047.md) for Q2 FY2026, three months to 2026-08-01, from the 10-Q filed Sep 4, 2026 (XBRL us-gaap:Revenues, accession 0001018840-26-000047).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,209](/filings/0001018840-25-000048.md) | [1,585 d](/filings/0001018840-26-000012.md) | [1,097](/filings/0001018840-26-000036.md) | [1,209](/filings/0001018840-26-000047.md) | [1,291](/filings/0001018840-25-000048.md) | [1,670 d](/filings/0001018840-26-000012.md) | [1,114](/filings/0001018840-26-000036.md) | [1,267](/filings/0001018840-26-000047.md) |
| Gross margin | % | [65.1%](/filings/0001018840-24-000087.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [14.8%](/filings/0001018840-25-000048.md) | [16.2% d](/filings/0001018840-26-000012.md) | [9.3%](/filings/0001018840-26-000036.md) | [17.1%](/filings/0001018840-26-000047.md) | [12.0%](/filings/0001018840-25-000048.md) | [14.1% d](/filings/0001018840-26-000012.md) | [8.0%](/filings/0001018840-26-000036.md) | [19.9%](/filings/0001018840-26-000047.md) |
| Net margin | % | [10.9%](/filings/0001018840-25-000048.md) | [11.8% d](/filings/0001018840-26-000012.md) | [7.3%](/filings/0001018840-26-000036.md) | [11.7%](/filings/0001018840-26-000047.md) | [8.8%](/filings/0001018840-25-000048.md) | [10.3% d](/filings/0001018840-26-000012.md) | [6.0%](/filings/0001018840-26-000036.md) | [14.5%](/filings/0001018840-26-000047.md) |
| Diluted EPS | $ per share | [2.50](/filings/0001018840-25-000048.md) | not reported | [1.59](/filings/0001018840-26-000036.md) | [2.91](/filings/0001018840-26-000047.md) | [2.36](/filings/0001018840-25-000048.md) | not reported | [1.47](/filings/0001018840-26-000036.md) | [4.17](/filings/0001018840-26-000047.md) |
| Free cash flow | $m | [92.2 d](/filings/0001018840-25-000048.md) | [257 d](/filings/0001018840-26-000012.md) | [(54.8)](/filings/0001018840-26-000036.md) | [50.7 d](/filings/0001018840-26-000047.md) | [132 d](/filings/0001018840-25-000048.md) | [251 d](/filings/0001018840-26-000012.md) | [(17.1)](/filings/0001018840-26-000036.md) | [201 d](/filings/0001018840-26-000047.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-29) | FY2022 (2023-01-28) | FY2023 (2024-02-03) | FY2024 (2025-02-01) | FY2025 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,713](/filings/0001018840-24-000019.md) | [3,698](/filings/0001018840-25-000013.md) | [4,281](/filings/0001018840-26-000012.md) | [4,949](/filings/0001018840-26-000012.md) | [5,266](/filings/0001018840-26-000012.md) |
| Gross margin | % | [62.3%](/filings/0001018840-24-000019.md) | [56.9%](/filings/0001018840-24-000019.md) | [62.9%](/filings/0001018840-24-000019.md) | not reported | not reported |
| Operating margin | % | [9.2%](/filings/0001018840-24-000019.md) | [2.5%](/filings/0001018840-25-000013.md) | [11.3%](/filings/0001018840-26-000012.md) | [15.0%](/filings/0001018840-26-000012.md) | [13.3%](/filings/0001018840-26-000012.md) |
| Net margin | % | [7.1%](/filings/0001018840-24-000019.md) | [0.1%](/filings/0001018840-25-000013.md) | [7.7%](/filings/0001018840-26-000012.md) | [11.4%](/filings/0001018840-26-000012.md) | [9.6%](/filings/0001018840-26-000012.md) |
| Diluted EPS | $ per share | [4.20](/filings/0001018840-24-000019.md) | [0.05](/filings/0001018840-25-000013.md) | [6.22](/filings/0001018840-26-000012.md) | [10.69](/filings/0001018840-26-000012.md) | [10.46](/filings/0001018840-26-000012.md) |
| Free cash flow | $m | [181](/filings/0001018840-24-000019.md) | [(167)](/filings/0001018840-25-000013.md) | [496](/filings/0001018840-26-000012.md) | [527](/filings/0001018840-26-000012.md) | [378](/filings/0001018840-26-000012.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/anf/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $545.9m | 6,064,331 |  | Added +90,891 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $327.4m | 3,637,893 |  | Added +2,278,744 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $220.7m | 2,451,749 |  | Added +35,588 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $212.8m | 2,428,332 |  | Reduced −1,019,630 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $181.6m | 2,017,220 |  | Added +394,993 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $181.3m | 2,014,665 |  | Reduced −37,748 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $165.0m | 1,832,781 |  | Added +236,604 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $164.1m | 1,822,751 |  | Added +52,515 |
| [BBFIT INVESTMENTS PTE LTD](/funds/2094345.md) | 2026-06-30 | $147.0m | 1,632,944 |  | Unchanged |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $124.3m | 1,380,924 |  | Added +70,628 |

## Recent filings

[All 1,551 filings](/companies/anf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-04 | 16:54 ET | [10-Q](/filings/0001018840-26-000047.md) | Quarterly report, period 2026-08-01 | 0001018840-26-000047 |
| 2026-08-26 | 07:38 ET | [8-K](/filings/0001018840-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001018840-26-000041 |
| 2026-08-20 | 16:31 ET | [8-K](/filings/0001018840-26-000039.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001018840-26-000039 |
| 2026-06-05 | 16:37 ET | [10-Q](/filings/0001018840-26-000036.md) | Quarterly report, period 2026-05-02 | 0001018840-26-000036 |
| 2026-06-04 | 16:32 ET | [8-K](/filings/0001018840-26-000034.md) | 5.07 Shareholder vote results | 0001018840-26-000034 |
| 2026-05-27 | 07:38 ET | [8-K](/filings/0001018840-26-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001018840-26-000029 |
| 2026-04-20 | 16:32 ET | [DEF 14A](/filings/0001018840-26-000022.md) | Proxy statement, period 2026-06-03 | 0001018840-26-000022 |
| 2026-03-26 | 17:18 ET | [10-K](/filings/0001018840-26-000012.md) | Annual report, period 2026-01-31 | 0001018840-26-000012 |
| 2026-03-04 | 07:34 ET | [8-K](/filings/0001018840-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001018840-26-000006 |
| 2026-01-12 | 08:04 ET | [8-K](/filings/0001018840-26-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001018840-26-000003 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001018840-26-000012.md), filed Mar 26, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1018840
- Tickers: ANF
- Exchange: NYSE
- SIC code: 5651 Retail-Family Clothing Stores
- State of incorporation: OH
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.